Alghazali, M. et al. 2020. Update on a real-world study evaluating overall survival and treatment duration in Swedish patients with metastatic castration-resistant prostate cancer treated with enzalutamide. Scandinavian Journal of Urology. 54, 3 (Mar. 2020), 263–264. DOI:https://doi.org/10.1080/21681805.2020.1750476.